| Gilead and Second Genome Sign US$1.5 B Microbiome-based Drug Discovery Deal |
Abstract
pdf
html
|
|
Sasha Yachu & Michelle Liu |
|
| Vertex Signs US$1.6 B Gene Therapy Vector Partnership with Affinia |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Dyno Therapeutics Launches with US$2 B Deals with Novartis and Sarepta |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Fate Therapeutics Partners with Janssen for iPSC-derived Immunotherapies |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Alexion Acquires Portola for US$1.44 B |
Abstract
pdf
html
|
|
Michelle Liu |
|
| PTC Therapeutics Acquires Censa Pharmaceuticals |
Abstract
pdf
html
|
|
Michelle Liu |
|
